Stolnik S, Dunn S E, Garnett M C, Davies M C, Coombes A G, Taylor D C, Irving M P, Purkiss S C, Tadros T F, Davis S S
Department of Pharmaceutical Sciences, Nottingham University, University Park, U.K.
Pharm Res. 1994 Dec;11(12):1800-8. doi: 10.1023/a:1018931820564.
The modification of surface properties of biodegradable poly(lactide-co- glycolide) (PLGA) and model polystyrene nanospheres by poly(lactide)-poly(ethylene glycol) (PLA:PEG) copolymers has been assessed using a range of in vitro characterization methods followed by in vivo studies of the nanospheres biodistribution after intravenous injection into rats. Coating polymers with PLA:PEG ratio of 2:5 and 3:4 (PEG chains of 5000 and 2000 Da. respectively) were studied. The results reveal the formation of a PLA:PEG coating layer on the particle surface resulting in an increase in the surface hydrophilicity and decrease in the surface charge of the nanospheres. The effects of addition of electrolyte and changes in pH on stability of the nanosphere dispersions confirm that uncoated particles are electrostatically stabilized, while in the presence of the copolymers, steric repulsions are responsible for the stability. The PLA:PEG coating also prevented albumin adsorption onto the colloid surface. The evidence that this effect was observed for the PLA:PEG 3:4 coated nanospheres may indicate that a poly(ethylene glycol) chain of 2000 Da can provide an effective repulsive barrier to albumin adsorption. The in vivo results reveal that coating of PLGA nanospheres with PLA:PEG copolymers can alter the biodistribution in comparison to uncoated PLGA nanospheres. Coating of the model polystyrene nanospheres with PLA:PEG copolymers resulted in an initial high circulation level, but after 3 hours the organ deposition data showed values similar to uncoated polystyrene spheres. The difference in the biological behaviour of coated PLGA and polystyrene nanospheres may suggest a different stability of the adsorbed layers on these two systems.(ABSTRACT TRUNCATED AT 250 WORDS)
通过一系列体外表征方法,评估了聚(丙交酯)-聚(乙二醇)(PLA:PEG)共聚物对可生物降解的聚(丙交酯-共-乙交酯)(PLGA)和模型聚苯乙烯纳米球表面性质的改性,随后对纳米球静脉注射到大鼠体内后的生物分布进行了体内研究。研究了PLA:PEG比例为2:5和3:4(PEG链分别为5000和2000 Da)的涂层聚合物。结果表明,在颗粒表面形成了PLA:PEG涂层,导致纳米球表面亲水性增加,表面电荷减少。添加电解质和pH值变化对纳米球分散体稳定性的影响证实,未涂层的颗粒通过静电稳定,而在共聚物存在下,空间排斥力负责稳定性。PLA:PEG涂层还防止了白蛋白吸附到胶体表面。对于PLA:PEG 3:4涂层的纳米球观察到这种效应的证据可能表明,2000 Da的聚(乙二醇)链可以为白蛋白吸附提供有效的排斥屏障。体内结果表明,与未涂层的PLGA纳米球相比,用PLA:PEG共聚物涂覆PLGA纳米球可以改变生物分布。用PLA:PEG共聚物涂覆模型聚苯乙烯纳米球导致初始循环水平较高,但3小时后器官沉积数据显示的值与未涂层的聚苯乙烯球相似。涂覆的PLGA和聚苯乙烯纳米球在生物学行为上的差异可能表明这两种系统上吸附层的稳定性不同。(摘要截断于250字)